Critical Care Nurse. 2008;28: 40-55
Copyright © 2008 by the American Association of Critical-Care Nurses.
Clinical Article
Depression in Patients With Heart Failure: Prevalence, Pathophysiological Mechanisms, and Treatment
Sue A. Thomas, RN, PhD
Deborah Wince Chapa, RN, PhD, ACNP-BC
Erika Friedmann, PhD
Cheryl Durden, RN, MS
Alyson Ross, RN, MS
Mei Ching Y. Lee, RN, MS
Hyeon-Joo Lee, RN, MS, ANP-C
Sue A. Thomas is a professor and assistant dean of the doctoral program, Erika Friedmann is a professor, and Cheryl Durden, Alyson Ross, Mei Ching Y. Lee, and Hyeon-Joo Lee are doctoral students at the School of Nursing, University of Maryland, in Baltimore.
Deborah Chapa is an assistant professor and program director of the acute care nurse practitioner program at Florida Gulf Coast University in Fort Myers. She is also director of midlevel providers of critical care services at Lee Memorial Health System, Fort Myers, Florida.
To purchase electronic or print reprints, contact The InnoVision Group, 101 Columbia, Aliso Viejo, CA 92656. Phone, (800) 809-2273 or (949) 362-2050 (ext 532); fax, (949) 362-2049; e-mail, reprints{at}aacn.org.
eLetters
Now that you’ve read the article, create or contribute to an online discussion about this topic using eLetters. Just visit http://ccn.aacnjournals.org and click "Respond to This Article" in either the full-text or PDF view of the article.
Financial Disclosures
This research was partially supported by grant R01 NR07613 from the National Institute of Nursing Research, Bethesda, Maryland.
dot
To learn more about depression in patients with heart failure, visit www.ajcconline.org and read the article by Heo et al, "Predictors and Effect of Physical Symptom Status on Health-Related Quality of Life in Patients With Heart Failure" (American Journal of Critical Care, March 2008).
Corresponding author: Sue A. Thomas, RN, PhD, University of Maryland, School of Nursing, 655 W Lombard St, Baltimore, MD 21201 (e-mail: Thomas{at}son.umaryland.edu).
As treatment of cardiovascular diseases improves and the population ages, the incidence and prevalence of heart failure are increasing. More than 5 million patients in the United States are living with heart failure, and 550 000 new cases are diagnosed each year.1 The estimated prevalence of depression is 100 cases per 1000 persons in the population more than 65 years old.2 Strong evidence3–11 links depression to increased morbidity and mortality in patients with coronary heart disease, the underlying cause of half of the cases of heart failure. Depression is associated with mortality in outpatients,12–15 inpatients,16 and hospitalized patients who have heart failure.17,18 The association of depression with mortality in these patients is independent of anxiety and social isolation. In a sample of patients (N=153) enrolled in the Sudden Cardiac Death in Heart Failure Trial, depression (P=.02, hazard ratio=2.2) was an independent predictor of mortality after controls for significant demographic and clinical predictors of mortality, anxiety, social support, and treatment group.13 On the basis of analysis via the Cox proportional hazards model, patients with mild depression were 2.2 times as likely to die as those who were not depressed.13 Mortality due to all causes was 12% for patients with depression and 9% for others.13
In this article, we describe a holistic model for cardiovascular health and apply it to depression in heart failure, summarize the pathophysiological changes in depression that may contribute to increased morbidity and mortality of patients with heart failure, and review the growing literature on the prevalence of depression in patients with heart failure. We also discuss assessment of depression in patients with heart failure and implications for nursing practice. Future research is proposed.
 |
Biopsychosocial Holistic Model of Cardiovascular Health
|
|---|
Thomas et al11,19–22 have proposed a holistic model of cardiovascular health in which biological, psychological, and social realms interact within each person and are integrated into health (Figure 1
). Health interacts with factors in each realm to affect all other realms. Acute and chronic shifts in each realm affect health status, and health status affects biological, social, and psychological factors. Psychosocial factors either promote health by moderating pathological processes or promote disease by enhancing the processes. In the psychological realm, depression, anxiety, and life stress diminish health.11,13 In the social realm, social support and pet ownership promote health.13,23–25 Social and psychological factors affect the biological factors. Depression alters levels of cortisol, catecholamines, and cytokines; autonomic neurocardiac regulation; and factors that influence cardiovascular functioning. The holistic model provides the basis for a dynamic interactive approach to the assessment and treatment of depression in patients with heart failure.
|
Impact of Pathophysiological Changes in Depression on Heart Failure
|
|---|
Examination of the physiology of depression in patients with heart failure illustrates the integration of physiological and psychological factors in cardiovascular health. Depression causes physiological changes that are associated with increased morbidity and mortality in patients with heart failure.22 Four pathological patterns that occur in depressed patients correspond to the pathogenesis of heart failure: neurohormonal activation,26,27 hyper-coagulability,26,27 autonomic neurocardiac dysfunction,26,27 and cytokine release27 (Figure 2). These pathophysiological changes are thought to mediate the increased risk for cardiac events in people who are depressed and the subsequent poor prognosis if such events occur.27–29
|
Neurohormonal Activation
|
|---|
Endogenous neurohormones are activated in patients with heart failure as a result of increased left ventricular filling pressure that stimulates the activation of norepinephrine, renin-angiotensin-aldosterone, vasopressin, and endothelin 1. Activation of these systems results in both vasoconstriction and volume expansion.28,30,31
Patients with depression experience increased activation of the nervous system via hyperreactivity of the hypothalamic-pituitary-adrenal axis, leading to increased release of cortisol into the bloodstream.26,27 Elevated levels of serum cortisol cause high blood pressure, high levels of blood lipids, insulin resistance, and abdominal obesity.26,27 Over time, these factors have a long-term deleterious effect.
Hyperactivity of the hypothalamic-pituitary-adrenal axis also mediates hyperreactivity of the sympathetic nervous system as indicated by elevated plasma levels of norepinephrine and increased catecholamine response to orthostatic challenge.32,33 Evidence supports a relationship between mortality and increased levels of catecholamines, most likely a result of a decrease in the number of β1-adrenergic receptor sites, decreased sensitivity to adrenergic stimulation, inadequate myocardial remodeling, myocardial toxic effects, and increased tendency for ventricular arrhythmias.27,28,30,31 Additional research is needed to determine if catecholamine levels are elevated in patients with heart failure who are depressed.
Both hypercortisolism and increased norepinephrine levels increase blood coagulation. Hyper-cortisolism causes increases in the levels of factor VIII and von Willebrand factor and a decrease in fibrinolysis. Elevated norepinephrine levels are associated with increased coagulation and fibrinolysis.34
|
Hypercoagulability
|
|---|
Increased platelet aggregation in cardiac patients who are depressed increases their vulnerability to thrombus formation, myocardial infarction, and stroke.28 Evidence of the effects of coagulation abnormalities in patients with heart failure is inconclusive. Abnormalities in platelet function in patients with untreated depression may cause platelet aggregation, leading to thrombus formation.35 Patients with depression have increases in the number of platelet receptors for serotonin 5-HT2A.36,37 Even though the relationship between these receptors and platelet activation is not known, platelet reactivity is reduced in patients treated with selective serotonin reuptake inhibitors (SSRIs), one type of antidepressant.38 Additional research is needed to determine the relationship between depression, platelets, and outcomes for patients with heart failure.27
|
Autonomic Neurocardiac Dysfunction
|
|---|
Changes in autonomic neurocardiac regulation occur both in patients with depression and in patients with heart failure. In heart failure and depression, patients experience increased sympathetic activity as well as decreased parasympathetic activity. In the healthy heart, the parasympathetic nervous system works as a homeostatic mechanism to balance sympathetic cardiac stimulation. Because of decreased parasympathetic activity in depression and heart failure, patients with these conditions are more likely to experience cardiac arrhythmias than are patients with other abnormalities. Heart rate variability, a measure of beat-to-beat alterations in heart rate, is used to measure autonomic neurocardiac dysfunction.39 The time domain measure of heart rate variability,40 which is the standard deviation of all normal-to-normal R-to-R intervals in a 24-hour period, strongly reflects circadian rhythms, as well as neuroendocrine rhythms, activity, and other factors.41 The normal standard deviation is greater than 100 milliseconds.42 Reduced heart rate variability correlates with reduced parasympathetic activity or decreased vagal tone and with increased mortality.41,43–46 Depression is associated with reduced heart rate variability in patients with heart failure.47,48
|
Cytokine Cascade
|
|---|
Cytokines are low-molecular-weight proteins that function as chemical communicators within and between cells. Although all of the mechanisms of actions of cytokines are not yet conclusively established, evidence indicates that these proteins are critical components in the immune response.49 According to their role in the immune response and inflammation, cytokines are categorized as proinflammatory or anti-inflammatory.50 The unique receptors for cytokines promote or inhibit the activities of these proteins. Cytokine inhibitors decrease potential tissue injuries by limiting a prolonged inflammatory response. Proinflammatory cytokines include interleukin 1 (IL-1), IL-6, and tumor necrosis factor 
(TNF-). Levels of IL-1, IL-6, and TNF- are elevated in patients with heart failure.
Three mechanisms are proposed to explain the actions of proinflammatory cytokines in heart failure. The first possibility is that cytokines are activated in response to the myocardial injury that triggers heart failure.50 The second possibility is that the heart is the source of TNF-. This increase in TNF- triggers a secondary activation of the immune system by triggering the hypothalamic-pituitary-adrenal axis and thereby increasing levels of corticosteroids.51 The third possibility is that the decreased cardiac output in heart failure causes underperfusion of systemic tissues and leads to the elaboration of TNF-. Edema of the gut wall allows translocation of endotoxin, which in turn induces cytokine production.52
Serum levels of IL-1, IL-6, and TNF- are elevated in patients with major depression.53 Elevation in cytokines produces inflammation. The end result of the inflammation is left ventricular remodeling, contractile dysfunction, and uncoupling of myocardial β-adrenergic receptors. TNF- increases pulmonary vascular permeability and pulmonary edema and produces myocardial necrosis.54
|
Clinical Features Common to Both Depression and Heart Failure
|
|---|
The overlapping signs and symptoms of depression and heart failure make the diagnosis of depression in patients with heart failure challenging.55–57 It is often unclear whether a patient’s signs and symptoms indicate heart failure or heart failure with depression.55–57
The essential feature required for the diagnosis of depression, according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV), the most recently published criteria for the diagnosis of psychiatric disorders, is a period of at least 2 weeks with depressed mood or a loss of interest in pleasurable activities58 (Table 1). A person with heart failure often has both of these symptoms because of the decreased cardiac output49 that accompanies heart failure. Decreased cardiac output leads to poor physical functioning. Poor physical function is associated with depressed mood and loss of interest, particularly in younger patients.57 Once this criterion is met, the diagnosis of clinical depression depends on the presence of 7 additional signs and symptoms. The presence of any 4 of them is required for a diagnosis of major depression and any 3 of them for a diagnosis of minor depression. Lack of appetite and weight loss in patients with heart failure may be a consequence of decreased mesenteric circulation and diminished ability to absorb nutrients.49 Weight gain is a consequence of water retention in heart failure.49 Hypersomnia, or sleeping for prolonged periods during the day, may also occur in patients with heart failure as a consequence of compromised cardiac output and low energy levels.49 Fatigue or loss of energy is a core symptom of both depression55,56 and heart failure.49 Patients with heart failure often report restlessness or insomnia at night caused by shortness of breath, orthopnea (degree of shortness of breath when lying flat), and paroxysmal nocturnal dyspnea (being awakened from sleep by shortness of breath).49 In a study by Redeker,55 when demographics, comorbid conditions, and physical function were controlled for, differences in depression between patients with heart failure and a control group of members of the community were explained by sleep disturbances, fatigue, and excessive daytime sleepiness. Feelings of worthlessness, trouble concentrating, and thoughts of dying can be caused by the poor general quality of life that often accompanies progressive heart failure.59,60
|
Assessment of Depression in Patients With Heart Failure
|
|---|
The 2 major challenges in evaluating depression in patients with heart failure are the setting in which the assessment is conducted and the variety of methods and tools used to measure depression.
Depression in patients with heart failure is assessed in either the hospital or the outpatient setting. When patients with heart failure are hospitalized, the purpose is to address acute exacerbations of the signs and symptoms of heart failure. The pathological changes that occur as a result of the episodes that lead to hospitalization can increase the signs and symptoms of depression.22 Once the heart failure is under control, the depressive signs and symptoms may abate. Assessment of depression in patients with heart failure is more reliable in outpatients whose signs and symptoms of heart failure are more stable.
Two basic methods are used to assess depression: structured diagnostic interviews conducted by trained clinicians and symptom inventory self-reports by patients. Diagnostic interviews are designed to categorize individuals as meeting or not meeting the DSM-IV criteria for major and minor depression. Diagnostic interviews must be conducted by trained mental health professionals, including nurses with appropriate training, who are unfamiliar to the patient. In face-to-face interviews, the level of depression may be underestimated because patients are reluctant to admit to symptoms of depression.61,62 Structured diagnostic interviews are time and personnel intensive.61,62
The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)63 and the Diagnostic Interview Schedule (DIS)64,65 are the 2 interviews used most often to detect major depression. The SCID-I is a semistructured interview designed to assess an individual’s experience, either lifetime or current, of categorically defined DSM-IV Axis I psychiatric disorders, including mood and anxiety disorders.63 The SCID-I takes 45 to 90 minutes to complete. The interrater reliability and test-retest reliability (
statistic) for major depressive disorder were 0.80 and 0.61, respectively, for the patients’ edition.66 The DIS is the fully structured questionnaire designed to provide reliable and valid detection of psychiatric disorders on the basis of the DSM-IV.64,65 The DIS takes 90 to 120 minutes to administer. With the SCID-I as a clinical standard, the sensitivity and specificity were 0.25 and 0.98, respectively.67 Interrater reliabilities ( statistic) of SCID-I for major depressive episode, suicidal ideation, and suicide attempts were 0.67, 0.76, and 0.80, respectively.68
Self-report symptom inventories provide quantification of the number and severity of depressive symptoms a person is experiencing during a specified time in relation to the continuum of possible symptom experience. The scores indicate the relative strength of the symptoms. Thresholds for symptom severity indicate categories of strength of the symptoms, for example mild, moderate, or severe. A familiar clinician often asks a patient to complete a depression symptom inventory. The inventory approach allows patients some confidentiality and privacy as they answer questions about their emotional states. Self-report symptom inventories are less expensive than diagnostic interviews because the former take less clinician time and can be self-administered.61,62
A summary of the self-report symptom inventories used to assess depression in studies of patients with heart failure is included in Table 2. It includes the name, use, number of items contained, the possible range of scores, and information about reliability and validity for each tool. The tools most commonly used to assess depression in patients with heart failure are the Geriatric Depression Scale,77 Center for Epidemiological Studies Depression Scale,76 Beck Depression Inventory and Beck Depression Inventory II,73 and the Zung Self-rating Depression Scale.92 The number of items on these scales ranges from 20 to 30. The scales are all written at an easy reading level, and each one takes less than 5 minutes to administer.89 All of these tools have good reliability and validity. Scales with fewer items, such as the Hospital Anxiety and Depression Scale,80 have lower sensitivity and specificity, indicating that they are less good for classifying patients correctly as depressed (false-positives) and incorrectly as not depressed (false-negatives). The Geriatric Depression Scale is slightly longer than the other tools and is specifically tailored for the older population in which heart failure is most common.
View this table:
[in this window]
[in a new window]
|
Table 2 Summary of the characteristics of the tools used to assess depression in studies of patients with heart failurea
|
|
The appropriate instrument to use to assess depression depends on the purpose and context of the assessment. The gold standard for diagnosing major depression in the community or in nonpsychiatric patients is screening with a self-report inventory followed by an interview to confirm the diagnosis.62 Symptom inventories are useful to examine the relative strength of symptoms of depression, especially in patients who have depressive symptoms that are not severe enough to constitute a psychiatric disorder. Symptom inventories are particularly useful for examining changes in depressive symptoms during the course of an individual’s life and the effectiveness of interventions for reducing depression.89
|
Prevalence of Depression in Patients With Heart Failure
|
|---|
Increased awareness of the potential role of depression in morbidity and mortality related to heart failure27,56,57 has led to assessment of the prevalence of depression among patients with heart failure. In a 2003 review22 of depression and heart failure, 8 articles, 5 on hospitalized patients and 3 on outpatients, provided data on the prevalence of depression among patients with heart failure. Now, 14 additional articles substantiate the evidence of the high prevalence of depression in patients with heart failure.
The prevalence of depression in patients with heart failure varies considerably from study to study. The wide range, 77.5% to 13%, reflects both the assessment settings and the tools used. Table 3 summarizes the 22 recent studies that provide prevalence of depression in patients with heart failure. The table includes the setting in which depression was assessed; the size, sex, and age of the sample population; the tool or tools used for assessment; and the prevalence of depression. Studies in which depression was assessed via chart review are not included; this method is unreliable because of inconsistent assessment, reporting, and documentation.22 In the 12 studies of hospitalized patients with heart failure, depression was assessed solely with self-report symptom inventories in 7,16,95,97–99,102,103 solely with interviews in 1,94 and with both self-report symptom inventories and interviews in 4.17,96,100,101
View this table:
[in this window]
[in a new window]
|
Table 3 Summary of characteristics of patients with heart failure included in studies of the prevalence of depression among patients with heart failure and of the tools used to assess depression in each study
|
|
The prevalence of depression in studies in which symptom inventories were used ranged from 77.5% with the Geriatric Depression Scale16 to 22.6% with the Medical Outcome Study Depression Questionnaire.87 Interviews with hospitalized patients resulted in a prevalence of 36% with the DIS100 or the DIS and SCID-I101 to 13.9% with the DIS after screening with the Beck Depression Inventory.17 In the 10 studies of outpatients with heart failure, depression was assessed solely with symptom inventories in 9,13,14,57,87,104–106,108,109 and solely with interviews in 1.107 The prevalence of depression in studies in which symptom inventories were used ranged from 48% with the Beck Depression Inventory57 to 13% with the Zung Self-rating Depression Scale.14 Interviews resulted in prevalences of 29% with the Primary Care Evaluation of Mental Disorders tool107 and 14% with the SCID-I.108 Outpatients had lower prevalence of depression than did inpatients, and interviews resulted in fewer diagnoses of depression in patients with heart failure than did symptom inventories.
Women are 1.7 times as likely as men to experience significant depression in their lifetimes110; however, most studies of depression in patients with heart failure do not provide separate data for men and women. In the single study57 that did, in outpatients with heart failure, 64% of the women and 44% of the men were depressed. The percentages of men and women who were included in studies of depression in patients with heart failure were examined to evaluate the effect of sex on the prevalence of depression. In the 2 studies with the highest proportion of men, prevalence of depression assessed with checklists ranged from 36%13 to 42%.105 Major depression was diagnosed by using the SCID-I in 14% of heart failure outpatients in a sample that was 83% men.105 The prevalence of depression in men and women with heart failure was similar. These data suggest that men with heart failure are more likely to become depressed than are men in the general population.
|
Treatment of Depression in Patients With Heart Failure
|
|---|
Although depression is a common comorbid condition in patients with heart failure, treatment of depression in patients with heart failure has not been specifically examined in any large clinical trial. The National Institute of Mental Health is currently funding a phase 2 clinical trial, Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure, to examine the use of the SSRI sertraline to reduce depression and to examine the effect of the drug on mortality and secondary cardiac incidents in patients with heart failure.111
Other nonpharmacological treatments of depression in patients with heart failure are promising. Exercise is widely accepted as helpful in relieving depression and improves functional ability and quality of life.61,112–114 In one study,115 the combination of biofeedback and relaxation decreased depression in patients with heart failure. Although exercise and biofeedback-relaxation are promising as interventions to decrease symptoms in patients with heart failure, their effectiveness in patients with heart failure who also have depression has not been addressed in clinical trials. Because the safety of pharmacological agents in the treatment of depression in patients with heart failure remains uncertain, nurse researchers should consider examining the efficacy of nondrug alternatives such of yoga, which has shown promise in reducing risk factors associated with cardiovascular disease116 and in alleviating depression.117,118
Electroconvulsive therapy is often used when patients with ischemic heart disease experience life-threatening depression.119 This therapy may be unsuitable for use in patients with heart failure because it often is followed by a period of bradycardia and hypotension and then sinus tachycardia and elevated blood pressure and even dysrhythmias.119,120 Research is needed to evaluate the risks and benefits of electroconvulsive therapy in patients with heart failure and depression.
Healthcare providers must rely on evidence from trials of treatment of depression after myocardial infarction to treat depression in patients with heart failure; and those results are inconclusive. In large clinical trials, antidepressant medication reduced depression, but not morbidity or mortality. In the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART), sertraline had no adverse effects on left ventricular ejection fraction and fewer adverse cardiovascular events than did a placebo in patients (N=369) hospitalized for acute myocardial infarction or unstable angina.121 More recently, in the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial,122 in patients with coronary artery disease (N=284), treatment with citalopram, an SSRI, for 12 weeks significantly reduced depression more than a placebo did; short-term psychotherapy had no benefit. In the Enhancing Recovery in Coronary Artery Disease (ENRICHD) clinical trial,123 cognitive behavioral therapy, supplemented with an SSRI when indicated, decreased depression significantly but did not alter cardiovascular morbidity or mortality in patients after myocardial infarction (N=2481).
Tricyclic antidepressants and SSRIs have been tested in cardiac patients and are the most commonly prescribed antidepressants in this population. Providers may be reluctant to prescribe antidepressants because the drugs have significant side effects and may interact with other medications. These concerns deserve serious consideration. Although possibly more effective than the SSRIs in relieving depression, tricyclic antidepressants can cause increased heart rate,124 orthostatic hypotension, conduction abnormalities, and hypertension.124–126 Nelson et al127 compared the SSRI paroxetine to the tricyclic antidepressant nortriptyline in patients with ischemic heart disease. Although depression scores improved in both groups, more patients in the nortriptyline group discontinued their antidepressant because of adverse events. In several studies with small sample sizes, SSRIs were modestly effective in relieving depression in patients with acute coronary syndrome128,129 but interacted with medications that used the cytochrome P450 pathway, thereby increasing the actions of those drugs.130 For example, administration of an SSRI to a patient taking coumadin elevated the patient’s international normalized ratio, increasing the likelihood of a bleeding episode.
|
Nursing Implications
|
|---|
Assessment
Nurses who care for patients with heart failure in critical care settings can benefit from an understanding of depression, its physiological basis, its contribution to the signs and symptoms of heart failure, and its role in the inability of depressed patients with heart failure to adhere to treatment. This knowledge will help nurses understand the importance of looking for depression as a contributor to hospitalization in patients with heart failure and the possibility that treatment of depression is necessary for the control of the signs and symptoms of heart failure. The signs and symptoms of heart failure can mask the signs and symptoms of depression. The shared physiological changes in depression and heart failure potentiate the progression of both diseases. Optimal treatment of heart failure in patients with significant depressive symptoms may not lead to improvement in the signs and symptoms of heart failure unless the depression is also treated.
All patients with heart failure should be screened for depression. Asking patients to complete a self-report symptom inventory and scoring it are a simple, reliable, and valid way to assess depressive symptoms. The Beck Depression Inventory II, Center for Epidemiological Studies Depression Scale, Geriatric Depression Scale, and the Zung Self-rating Depression Scale are all appropriate for use in patients with heart failure. Patients who give answers indicative of suicidal ideation, for example, "I would like to kill myself," or "I would kill myself if I had the chance," on the Beck Depression Inventory II require immediate referral to mental health services. Patients with assessment scores indicative of depression should be referred to a mental health counselor for further evaluation with a clinical interview and/or services. The risk from unnecessarily referring a patient to a mental health counselor is minimal compared with the potential to help patients whose heart failure hides their depression.131
Numerous studies document an association between depression and poor compliance with medical regimens and poor health outcomes.132 Improvement in depressive symptoms can also improve medication compliance in cardiac patients, including those without clinical depression.133
Caregivers of patients with heart failure also may experience depression.134 Their depression may affect their ability to help patients with heart failure comply with medical treatment. Depression in the care-givers of patients with heart failure has been associated with increased hospitalizations of the patients.135
Social Support
Social support provided by nurses may help alleviate depressive symptoms and improve quality of life in patients with heart failure who have such symptoms. A lack of social support is correlated with higher depression and low remission of depression in patients with heart failure.96 Among cardiac outpatients, social support is inversely related to depressive symptoms.15,136 In a study of 887 patients with acute myocardial infarction, social support intervention led to improvement in depressive symptoms; decreased depressive symptoms were associated with decreased mortality of depressed cardiac patients with high distress.6
Nurses can apply this information to provide social support for hospitalized patients with heart failure. Nurses can educate the families of depressed patients with heart failure about the importance of social support for these patients. Awareness of the connection between social support and its impact on depression will encourage nurses to assess their patients for adequate social support and assist in providing avenues of increased social support such as cardiac support groups.
Patient and Family Education
Patients and their families may lack an understanding of the diagnosis of depression, its underlying physiological mechanisms, and the interrelationship between depression and heart failure. It is therefore important for patients and their families to understand the common physiological causes of depression in patients with heart failure in layman’s terms and that symptoms of depression are due to physiological changes and do not necessarily constitute mental incompetence.137 Patients and their family members also require education about the options for treating depression, side effects of the options, the duration of treatment required for treatment benefits to begin, the possibility that a series of different treatments may be required to obtain effective relief of depression, and the improvement in quality of life that accompanies improvement in depression.138
Areas for Nursing Research
Nursing literature on the care of patients with heart failure focuses primarily on psychosocial aspects.139–141 Interventions involving goal setting and education significantly improve quality of life in patients with heart failure.142,143 The effect of depression on the quality of life of patients with heart failure has not been examined. Randomized trials on the efficacy of a variety of nondrug interventions, including exercise, yoga, counseling, stress management, and patient and family support and education are needed to guide nursing care of depressed patients with heart failure.
|
Conclusion
|
|---|
Increasing evidence supports depression as a frequent comorbid condition in patients with heart failure. Nurses using a holistic model to understand the integration of mind and body into health status can improve the assessment and treatment of patients with heart failure who are depressed. Detection of clinical depression in patients with heart failure requires screening with a self-report symptom inventory followed by a structured interview to confirm and validate the diagnosis. Even subclinical depression, indicated by elevated scores on the symptom inventories, affects health outcomes. The major pathophysiological changes that occur in both depression and heart failure have potential deleterious effects on the heart. The most effective treatment for depression in patients with heart failure has not been established. Depression is associated with poor compliance with medical regimens. Treatment of depression improves both depression and compliance. Research is needed to determine which treatment is most effective and whether the treatment of depression will improve morbidity and mortality in patients with heart failure and depression.
|
PRIME POINTS
|
|---|
- Depression is a common comorbid condition in patients with heart failure.
- Biological, psychological, and social aspects of morbidity and mortality in heart failure can be integrated in a holistic model.
- Four major pathophysiological changes occur both in patients with depression and in patients with heart failure.
- Detect depression in patients with heart failure by using a symptom inventory and then an interview to confirm the results.
|
References
|
|---|
- Rosamond W, Flegal K, Friday G, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [published correction appears in Circulation. 2007;115(6):e172]. Circulation. 2007;115(5):e69–e171.[Free Full Text]
- McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000;83(5):596–602.[Free Full Text]
- Ahern DK, Gorkin L, Anderson JL, et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol. 1990; 66(1):59–62.[Medline]
- Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93:1976–1980.[Abstract/Free Full Text]
- Frasure-Smith N, Koszycki D, Swenson JR, et al. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE) [published correction appears in Psychosom Med. 2007;69(2):216]. Psychosom Med. 2006;68(1):87–93.[Abstract/Free Full Text]
- Frasure-Smith N, Lespérance F, Gravel G, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101(16):1919–1924.[Abstract/Free Full Text]
- Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction [published correction appears in Circulation. 1998;97(7):708]. Circulation. 1995;91(4):999–1005.[Abstract/Free Full Text]
- Lespérance F, Frasure-Smith N. Depression and heart disease. Cleve Clin J Med. 2007;74(suppl 1):S63–S66.[Free Full Text]
- Lespérance F, Frasure-Smith N. Depression and coronary artery disease: time to move from observation to trials. CMAJ. 2003;168(5):570–571.[Free Full Text]
- Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002; 105(9):1049–1053.[Abstract/Free Full Text]
- Thomas SA, Friedmann E, Wimbush F, Schron E. Psychological factors and survival in the Cardiac Arrhythmia Suppression Trial (CAST): a reexamination. Am J Crit Care. 1997;6(9):116–126.[Abstract]
- Faris R, Purcell H, Henein MY, Coats AJS. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail. 2002;4(4):541–551.[Abstract/Free Full Text]
- Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS; Sudden Cardiac Death in Heart Failure Trial Investigators. Relationship of depression, anxiety, and social isolation to chronic heart failure out-patient mortality. Am Heart J. 2006;152(5): 940.e2–940.e8.
- Murberg TA, Bru E, Aarsland T, Svebak S. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med. 1998;28(3):273–291.[Medline]
- Murberg TA, Bru E. Social relationships and mortality in patients with congestive heart failure. J Psychosom Res. 2001;51(3):521–527.[Medline]
- Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001;38:199–205.[Abstract/Free Full Text]
- Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161(15):1849–1856.[Abstract/Free Full Text]
- Jiang W, Kuchibhatla M, Cuffe MS, et al. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation. 2004;110(222):3452–3456.[Abstract/Free Full Text]
- Thomas SA, Liehr P, DeKeyser F, Frazier L, Friedmann E. A review of nursing research on blood pressure. J Nurs Scholarsh. 2002; 34(4):313–321.[Medline]
- Thomas SA, Liehr P. Cardiovascular reactivity during verbal communication: an emerging risk factor. J Cardiovasc Nurs. 1995;9:1–11.[Medline]
- Thomas SA, Liehr P, DeKeyser F, Friedmann E. Nursing blood pressure research, 1980–1990: a bio-psycho-social perspective. Image J Nurs Sch. 1993;25(2):157–164.[Medline]
- Thomas SA, Friedmann E, Khatta M, Cook LK, Lann AL. Depression in patients with heart failure: physiologic effects, incidence, and relation to mortality. AACN Clin Issues. 2003;14:3–12.[Medline]
- Friedmann E, Thomas SA, Stein PK, Kleiger RE. Relation between pet ownership and heart rate variability in patients with healed myocardial infarcts. Am J Cardiol. 2003;91:718–721.[Medline]
- Friedmann E, Thomas SA. Pet ownership, social support, and one-year survival after acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial (CAST). Am J Cardiol. 1995;76:1213–1217.[Medline]
- Friedmann E, Katcher AH, Thomas SA, Lynch JJ, Messent PR. Social interaction and blood pressure: influence of animal companions. J Nerv Ment Dis. 1983;171(8):461–465.[Medline]
- Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004;55:1–9.[Medline]
- Joynt KE, Whellan DJ, O’Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail. 2004;10:258–271.[Medline]
- Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998; 55:580–592.[Abstract/Free Full Text]
- Nair GV, Gurbel PA, O’Connor CM, Gattis WA, Murugesan SR, Serebruany VL. Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors. Am J Cardiol. 1999;84(3):321–323, A8.[Medline]
- Pepper GS, Lee RW. Sympathetic activation in heart failure and its treatment with β-blockade. Arch Intern Med. 1999;159(3): 225–234.[Abstract/Free Full Text]
- Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol. 2001;21:661–672.[Medline]
- Gold PW, Gabry KE, Yasuda MR, Chrousos GP. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin North Am. 2002; 31:37–62.[Medline]
- Maas JW, Katz MM, Koslow SH, et al. Adrenomedullary function in depressed patients. J Psychiatr Res. 1994;28:357–367.[Medline]
- von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med. 2001;63:531–544.[Abstract/Free Full Text]
- Musselman DL, Nemeroff CB. Depression really does hurt your heart: stress, depression, and cardiovascular disease. Prog Brain Res. 2000;122:43–59.[Medline]
- Hrdina PD, Bakish D, Chudzik J, Ravindran A, Lapierre YD. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci. 1995;20(1):11–19.[Medline]
- Neuger J, El Khoury A, Kjellman BF, Wahlund B, Aberg-Wistedt A, Stain-Malmgren R. Platelet serotonin functions in untreated major depression. Psychiatry Res. 1999; 85(2):189–198.[Medline]
- Nemeroff CB, Musselman DL. Are platelets the link between depression and ischemic heart disease? Am Heart J. 2000;140:57–62.[Medline]
- Low PA, Pfeifer MA. Standardization of autonomic function. In: Low PA, ed. Clinical Autonomic Disorders: Evaluation and Management. Philadelphia, PA: Lippincott-Raven Publishers; 1997:287–295.
- Woods SL, Froelicher ES, Motzer SU, Bridges EJ. Cardiac Nursing. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
- Krüger C, Lahm T, Zugck C, et al. Heart rate variability enhances the prognostic value of established parameters in patients with congestive heart failure. Z Kardiol. 2002;91(12):1003–1012.[Medline]
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043–1065.[Free Full Text]
- Bar KJ, Greiner W, Jochum T, Friedrich M, Wagner G, Sauer H. The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. J Affect Disord. 2004;82:245–252.[Medline]
- Guzzetti S, Magatelli R, Borroni E, Mezzetti S. Heart rate variability in chronic heart failure. Auton Neurosci. 2001;90(1–2):102–105.[Medline]
- Jiang W, Hathaway WR, McNulty S, et al. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol. 1997;80:808–811.[Medline]
- Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Circulation. 1998;98(15):1510–1516.[Abstract/Free Full Text]
- Straburzynska-Migaj E, Ochotny R, Wachowiak-Baszynska A, et al. Cytokines and heart rate variability in patients with chronic heart failure. Kardiol Pol. 2005;63:478–485.[Medline]
- Guinjoan SM, Castro MN, Vigo DE, et al. Depressive symptoms are related to decreased low-frequency heart rate variability in older adults with decompensated heart failure. Neuropsychobiology. 2007;55:219–224.[Medline]
- McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 5th ed. St Louis, MO: Mosby; 2006.
- Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom Med. 2003;65:181–193.[Abstract/Free Full Text]
- Kapadia S, Dibbs Z, Kurrelmeyer K, et al. The role of cytokines in the failing human heart. Cardiol Clin. 1998;16:645–656.[Medline]
- Rauchhaus M, Koloczek V, Volk H, et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol. 2000; 76:125–133.[Medline]
- O’Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol. 2004;19:397–403.[Medline]
- Blum A, Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med. 2001;52:15–27.[Medline]
- Redeker NS. Somatic symptoms explain differences in psychological distress in heart failure patients vs a comparison group. Prog Cardiovasc Nurs. 2006;21(4):182–189.[Medline]
- O’Connor CM, Joynt KE. Depression: are we ignoring an important comorbidity in heart failure? J Am Coll Cardiol. 2004;43:1550–1552.[Free Full Text]
- Gottlieb SS, Khatta M, Friedmann E, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol. 2004;43: 1542–1549.[Abstract/Free Full Text]
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
- Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002;87(3):235–241.[Abstract/Free Full Text]
- Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002;23:1867–1876.[Abstract/Free Full Text]
- Johansson P, Dahlstrom U, Brostrom A. Factors and interventions influencing health-related quality of life in patients with heart failure: a review of the literature. Eur J Cardiovasc Nurs. 2006;5:5–15.[Medline]
- Johansson P, Dahlstrom U, Brostrom A. The measurement and prevalence of depression in patients with chronic heart failure. Prog Cardiovasc Nurs. 2006;21:28–36.[Medline]
- First MB, Spitzer RL, Williams JB. Structured Clinical Interview for DSM-IV (SCID-I): User’s Guide and Interview. Research Version. New York, NY: Biometrics Research Department, New York Psychiatric Institute; 1995.
- Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38(4):381–389.[Abstract/Free Full Text]
- Robins LN, Marcus L, Reich W. Diagnostic Interview Schedule, Version IV. St Louis, MO: Department of Psychiatry, Washington University School of Medicine; 1996.
- Zanarini MC, Skodol AE, Bender D, et al. The Collaborative Longitudinal Personality Disorders Study: reliability of Axis I and II diagnoses. J Personal Disord. 2000;14(4): 291–299.[Medline]
- Murphy JM, Monson RR, Laird NM, Sobol AM, Leighton AH. A comparison of diagnostic interviews for depression in the Stirling County study: challenges for psychiatric epidemiology. Arch Gen Psychiatry. 2000; 57:230–236.[Abstract/Free Full Text]
- Horton J, Compton WM, Cottler LB. Assessing psychiatric disorders among drug users: reliability of the revised DIS-IV. In: Harris L, ed. NIDA Research Monograph: Problems of Drug Dependence 1998. Washington, DC: National Institutes of Health; 1998:205. NIH Publication 99–4395.
- Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.[Abstract/Free Full Text]
- Skorikov V, Vandervoort DJ. Relationships between the underlying constructs of the Beck Depression Inventory and the Center for Epidemiological Studies Depression Scale. Educ Psychol Meas. 2003;63(2):319–335.[Abstract/Free Full Text]
- Uher R, Farmer A, Maier W, et al. Measuring depression: comparison and integration of three scales in the GENDEP study [published online ahead of print October 2007]. Psychol Med. doi:10.1017/S0033291707001730.
- Fountoulakis KN, Bech P, Panagiotidis P, et al. Comparison of depressive indices: reliability, validity, relationship to anxiety and personality and the role of age and life events. J Affect Disord. 2007;97:187–195.[Medline]
- Beck AT, Stter RA, Brown GK. BDI-II Beck Depression Inventory Manual. 2nd ed. San Antonio, TX: Harcourt Brace; 1996.
- Golden J, Conroy RM, O’Dwyer AM. Reliability and validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory (Full and FastScreen scales) in detecting depression in persons with hepatitis C. J Affect Disord. 2007;100(1–3): 265–269.[Medline]
- Di BM, Lindner H, Hare DL, Kent S. Depression following acute coronary syndromes: a comparison between the Cardiac Depression Scale and the Beck Depression Inventory II. J Psychosom Res. 2006;60:13–20.[Medline]
- Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1: 385–401.
- Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17:37–49.[Medline]
- Koenig HG, Meador KG, Cohen HJ, Blazer DG. Self-rated depression scales and screening for major depression in the older hospitalized patient with medical illness. J Am Geriatr Soc. 1988;36:699–706.[Medline]
- Logsdon RG, Teri L. Depression in Alzheimer’s disease patients: caregivers as surrogate reporters. J Am Geriatr Soc. 1995; 43:150–155.[Medline]
- Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370.[Medline]
- Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry. 2007;29:417–424.[Medline]
- Tagay S, Herpertz S, Langkafel M, et al. Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res. 2006;15:695–703.[Medline]
- Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.[Free Full Text]
- Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry. 2004;161:2163–2177.[Abstract/Free Full Text]
- Kobak KA, Lipsitz JD, Feiger A. Development of a standardized training program for the Hamilton Depression Scale using Internet-based technologies: results from a pilot study. J Psychiatr Res. 2003;37:509–515.[Medline]
- Iannuzzo RW, Jaeger J, Goldberg JF, Kafantaris V, Sublette ME. Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scale. Psychiatry Res. 2006;145:21–37.[Medline]
- Rumsfeld JS, Havranek E, Masoudi FA, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42:1811–1817.[Abstract/Free Full Text]
- Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26:775–789.[Medline]
- Mulrow CD, Williams JW Jr, Gerety MB, Ramirez G, Montiel OM, Kerber C. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995; 122:913–921.[Abstract/Free Full Text]
- Fisher KM, Copenhaver V. Assessing the mental health of rural older adults in public housing facilities: a comparison of screening tools. J Gerontol Nurs. 2006;32:26–33.[Medline]
- Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749–1756.[Abstract/Free Full Text]
- Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70.[Abstract/Free Full Text]
- Groth-Marnat G. The Handbook of Psychological Assessment. 2nd ed. New York, NY: John Wiley & Sons; 1990.
- Freedland KE, Carney RM, Rich MW, Carnacciolo A, Krotenburg JA, Sperry J. Depression in elderly patients with heart failure. J Geriatr Psychiatry. 1991;24:59–71.
- Fraticelli A, Gesuita R, Vespa A, Paciaroni E. Congestive heart failure in the elderly requiring hospital admission. Arch Gerontol Geriatr. 1996;23:225–238.[Medline]
- Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998;20:29–43.[Medline]
- Friedman MM, Griffin JA. Relationship of physical symptoms and physical functioning to depression in patients with heart failure. Heart Lung. 2001;30(2):98–104.[Medline]
- Tsay SL, Chao YF. Effects of perceived self-efficacy and functional status on depression in patients with chronic heart failure. J Nurs Res. 2002;10:271–278.[Medline]
- De Geest S, Scheurweghs L, Reynders I, et al. Differences in psychosocial and behavioral profiles between heart failure patients admitted to cardiology and geriatric wards. Eur J Heart Fail. 2003;5:557–567.[Abstract/Free Full Text]
- Freedland KE, Rich MW, Skala JA, Carney RM, Dávila-Román VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2003;65(1):119–128.[Abstract/Free Full Text]
- Fulop G, Strain JJ, Stettin G. Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization. Psychosomatics. 2003; 44:367–373.[Abstract/Free Full Text]
- Jünger J, Schellberg D, Müller-Tasch T, et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail. 2005;7:261–267.[Medline]
- Rumsfeld JS, Jones PG, Whooley MA, et al. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J. 2005;150:961–967.[Medline]
- Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol. 1999;84(3):348–350.[Medline]
- Skotzko CE, Krichten C, Zietowski G, et al. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail. 2000;6:300–305.[Medline]
- Steptoe A, Mohabir A, Mahon NG, McKenna WJ. Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy. Heart. 2000;83(6):645–650.[Abstract/Free Full Text]
- Sullivan M, Levy WC, Russo JE, Spertus JA. Depression and health status in patients with advanced heart failure: a prospective study in tertiary care. J Card Fail. 2004;10: 390–396.[Medline]
- Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JG. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail. 2005;7:803–808.[Medline]
- Westlake C, Dracup K, Fonarow G, Hamilton M. Depression in patients with heart failure. J Card Fail. 2005;11:30–35.[Medline]
- Kessler RC, Berglund P, Demler O, et al; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105.[Abstract/Free Full Text]
- National Institute of Mental Health. Antidepressant medication treatment for depression in individuals with chronic heart failure. ClinicalTrials.gov Web site. http://clinicaltrials.gov/ct/show/NCT00078286. Updated February 27, 2007. Accessed January 22, 2008.
- Witham MD, Struthers AD, McMurdo ME. Exercise training as a therapy for chronic heart failure: can older people benefit? J Am Geriatr Soc. 2003;51:699–709.[Medline]
- Gary RA, Sueta CA, Dougherty M, et al. Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung. 2004;33:210–218.[Medline]
- Koukouvou G, Kouidi E, Iacovides A, Konstantinidou E, Kaprinis G, Deligiannis A. Quality of life, psychological and physiological changes following exercise training in patients with chronic heart failure. J Rehabil Med. 2004;36:36–41.[Medline]
- Moser D, Stebenson L. Biobehavioral therapy in the management of patients with heart failure. In: Moser DK, Reigel B, eds. Improving Outcomes in Heart Failure: An Interdisciplinary Approach. Gaithersburg, MD: Aspen; 2001:152–162.
- Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract. 2005;18:491–519.[Medline]
- Krishnamurthy MN, Telles S. Assessing depression following two ancient Indian interventions: effects of yoga and ayurveda on older adults in a residential home. J Gerontol Nurs. 2007;33:17–23.[Medline]
- Woolery A, Myers H, Sternlieb B, Zeltzer L. A yoga intervention for young adults with elevated symptoms of depression. Altern Ther Health Med. 2004;10(2):60–63.[Medline]
- Jiang W, Blumenthal JA. Depression and ischemic heart disease: overview of the evidence and treatment implications. Curr Psychiatry Rep. 2003;5:47–54.[Medline]
- Rayburn BK. Electroconvulsive therapy in patients with heart failure or valvular heart disease. Convuls Ther. 1997;13(3):145–156.[Medline]
- Glassman AH, O’Connor CM, Califf RM, et al; Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina [published correction appears in JAMA. 2002;288(14):1720]. JAMA. 2002;288(6): 701–709.[Abstract/Free Full Text]
- Lespérance F, Frasure-Smith N, Koszycki D, et al; CREATE Investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial [published correction appears in JAMA. 2007; 298(1):40]. JAMA. 2007;297(4):367–379.[Abstract/Free Full Text]
- Mendes de Leon CF, Czajkowski SM, Freedland KE, et al; ENRICHD Investigators. The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial. J Cardiopulm Rehabil. 2006;26(1):9–13.[Medline]
- Roose SP. Treatment of depression in patients with heart disease. Biol Psychiatry. 2003; 54:262–268.[Medline]
- Alvarez W Jr, Pickworth KK. Safety of anti-depressant drugs in the patient with cardiac disease: a review of the literature. Pharmacotherapy. 2003;23:754–771.[Medline]
- Spina E, Scordo MG. Clinically significant drug interactions with antidepressants in the elderly. Drugs Aging. 2002;19:299–320.[Medline]
- Nelson JC, Kennedy JS, Pollock BG, et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry. 1999;156:1024–1028.[Abstract/Free Full Text]
- Serebruany VL, Glassman AH, Malinin AI, et al. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis. 2003;14:563–567.[Medline]
- Serebruany VL, Glassman AH, Malinin AI, et al; Sertraline Antidepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) platelet substudy [published correction appears in Circulation. 2003;108(25):3165]. Circulation. 2003;108(8):939–944.[Abstract/Free Full Text]
- Parissis JT, Fountoulaki K, Filippatos G, Adamopoulos S, Paraskevaidis I, Kremastinos D. Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications. Int J Cardiol. 2007;116:153–160.[Medline]
- Guck TP, Elsasser GN, Kavan MG, Barone EJ. Depression and congestive heart failure. Congest Heart Fail. 2003;9(3):163–169.[Medline]
- DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107.[Abstract/Free Full Text]
- Rieckmann N, Gerin W, Kronish IM, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol. 2006;48: 2218–2222.[Abstract/Free Full Text]
- Martensson J, Dracup K, Canary C, Fridlund B. Living with heart failure: depression and quality of life in patients and spouses. J Heart Lung Transplant. 2003;22:460–467.[Medline]
- Schwarz KA, Elman CS. Identification of factors predictive of hospital readmissions for patients with heart failure. Heart Lung. 2003;32:88–99.[Medline]
- Holahan CJ, Moos RH, Holahan CK, Brennan PL. Social support, coping, and depressive symptoms in a late-middle-aged sample of patients reporting cardiac illness. Health Psychol. 1995;14:152–163.[Medline]
- Williams JW Jr, Noel PH, Cordes JA, Ramirez G, Pignone M. Is this patient clinically depressed? JAMA. 2002;287:1160–1170.[Abstract/Free Full Text]
- Depression Guideline Panel. Depression in Primary Care: Detection and Diagnosis. Vol. 1. Rockville, MD: US Dept of Health and Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93–0550.
- Luttik ML, Jaarsma T, Moser D, Sanderman R, van Veldhuisen DJ. The importance and impact of social support on outcomes in patients with heart failure: an overview of the literature. J Cardiovasc Nurs. 2005; 20:162–169.[Medline]
- Moser DK, Worster PL. Effect of psychosocial factors on physiologic outcomes in patients with heart failure. J Cardiovasc Nurs. 2000;14:106–115.[Medline]
- Artinian NT. The psychosocial aspects of heart failure. Am J Nurs. 2003;103(12):32–42.[Medline]
- Kutzleb J, Reiner D. The impact of nurse-directed patient education on quality of life and functional capacity in people with heart failure. J Am Acad Nurse Pract. 2006; 18:116–123.[Medline]
- Scott LD, Setter-Kline K, Britton AS. The effects of nursing interventions to enhance mental health and quality of life among individuals with heart failure. Appl Nurs Res. 2004;17:248–256.[Medline]
Top
Biopsychosocial Holistic Model...
Impact of Pathophysiological...
indicates increase; 
indicates decrease.